IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $265,816 | +120178.7% | 37,758 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $221 | +0.9% | 36,373 | +5.8% | 0.00% | 0.0% |
| Q4 2022 | $219 | -99.9% | 34,373 | +11.3% | 0.00% | -50.0% |
| Q3 2022 | $295,000 | -15.0% | 30,873 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $347,000 | -8.0% | 31,555 | +39.1% | 0.00% | 0.0% |
| Q1 2022 | $377,000 | -13.9% | 22,684 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $438,000 | +5375.0% | 22,992 | +6469.1% | 0.00% | – |
| Q3 2021 | $8,000 | -38.5% | 350 | -30.0% | 0.00% | – |
| Q2 2021 | $13,000 | -13.3% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | -34.8% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | -23.3% | 500 | -45.2% | 0.00% | – |
| Q3 2020 | $30,000 | +25.0% | 912 | +5.7% | 0.00% | – |
| Q2 2020 | $24,000 | -14.3% | 863 | -7.2% | 0.00% | – |
| Q1 2020 | $28,000 | +33.3% | 930 | +24.0% | 0.00% | – |
| Q4 2019 | $21,000 | +2000.0% | 750 | +814.6% | 0.00% | – |
| Q1 2019 | $1,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |